Procyanidin regulates lipid metabolism through gut microbiota

傅颖,梅松,刘冬英,吴旧生
DOI: https://doi.org/10.13200/j.cjb.2013.02.86.fuy.024
2013-01-01
Abstract:Objective Objectives To investigate the possible mechanism of procyanidin (PC) in regulating lipid metabolism through gut microbiota. Methods Male adult SD rats and Meriones unguiculatus were fed with basal forage for one week, of which the serum samples were collected and determined for total cholesterol (TC) level. These animals were divided into six groups according to their TC levels and bodyweights. The animals in normal control group were fed with common forage, while those in the other five groups with high lipid forage. The animals in three test groups were treated with PC by oral route at low (25 mg/kg), moderate (100 mg/kg) and high (150 mg/kg) dosages respectively, while those in positive control group with Fenofibrate at a dosage of 80 mg/kg, once a day for 8 (rats) and 2 (M. unguiculatus ) weeks. The rats were killed at end of 8 weeks, while M. unguiculatus at end of 2 weeks, of which serum samples were collected. However, the fecal samples of animals within 72 h before being killed were collected. The TC, triglyceride (TG), high density lipoproteinprotein cholesterol (HUlAl), low-density lipoprotein cholesterol (LDIy-C) and total bile acid (TBA) levels in sera were determined by full-automatic biochemical analyzer, while the TBA level in feces by enzymalic cycling assay kit, and the lecithin cholesterol acyl transferase (LCAT) activity by two-step double antibody sandwich ELISA. The histopathology of killed animals was observed. The genomic DNAs were extracted from bacteria in small intestines and intestinum caecum of the animals, and analyzed for the changes of predominant bacteria of gut microbiota by PCR-denaturing gradient gel electrophoresis (DGGE). Results The TC and TG levels of animals in model control group were significandy higher than those in normal control group (P< 0. 05), indicating successful establishment of animal model of hyperlipidemia. As compared with those in model control group, the serum TC, TG, LDL-C and TBA levels in three test groups decressed significantly, while LCAT activity and fecal TBA level increased significantly (each P < 0. 05). The liver lesion, hepatic cell swelling and degeneration in three test groups significantly improved. DGGE and imaging showed that the diversity of predominant bacteria from gut microbiota in three test groups increased significantly, while decreased significantly with the increasing dosage of TC. The bacterial profile of M. unguiculatus treated with 25 mg/kg PC was similar to that in model control group. However, the diversity of gut microbiota decreased significantly, and the predominant bacteria showed an obvious tendency of restoration, in 100 and 150 mg/kg group. Conclusion The predominant bacterial profile of gut microbiota of experimental animal model showed an obviouse tendency of restoration after intervention by PC and dosages of 100 and 150 mg/kg, indicating the PC might regulate the lipid metabolism via gut microbiota pathway.
What problem does this paper attempt to address?